Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-18

FDA Approved: CEVIMELINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves cevimeline hydrochloride under the Original Application by Aurobindo Pharma Limited for treatment of Sjögren's syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cevimeline hydrochloride (cevimeline hydrochloride)

Snippet

ORIG AP for CEVIMELINE HYDROCHLORIDE (CEVIMELINE HYDROCHLORIDE)